CRISPR‑Cas9 engineered Saccharomyces cerevisiae for endolysin delivery to combat Listeria monocytogenes - Sáez Moreno, David; Cunha, Joana; Melo, Luís Daniel Rodrigues; Tanaka, Kenya; Bamba, Takahiro; Hasunuma, Tomosiha; Azeredo, Joana; Domingues, Lucília (Applied microbiology and biotechnology, 2025)
Keywords: Anti-Bacterial Agents - metabolism; Anti-Bacterial Agents - pharmacology; antibacterial properties; Bacteria; bacteriophages; Bacteriophages - enzymology; Bacteriophages - genetics; Biocontrol; Biological control; Biomedical and Life Sciences; Biotechnologically Relevant Enzymes and Proteins; Biotechnology; Cell walls; Central nervous system; CRISPR; CRISPR-Cas Systems; death; Endolysin; Endopeptidases - genetics; Endopeptidases - metabolism; Endopeptidases - pharmacology; Engineered Saccharomyces cerevisiae; Food consumption; Food contamination; Gastroenteritis; gene deletion; genome; Life Sciences; Listeria; Listeria monocytogenes; Listeria monocytogenes - drug effects; Listeriosis; Listeriosis - microbiology; Listeriosis - prevention & control; Microbial Genetics and Genomics; Microbiology; milk; Phages; Plasmids; Probiotics; risk; Saccharomyces cerevisiae; Saccharomyces cerevisiae - genetics; Saccharomyces cerevisiae - metabolism; secretion; serotypes; therapeutics; Yeast; yeasts; Engineered; Endolysin; Probiotics; CRISPR-Cas9; Biocontrol; Listeria monocytogenes; Engineered Saccharomyces cerevisiae